Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 1-year average of -3261.87%, near the high end of its 1-year range (-8352.26%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -3261.87%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-3261.87%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Oculis Holding AG
Market Cap
$495.09M
Operating Margin
0.00%
TTM Avg
-3261.87%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$489.40M
Operating Margin
13.16%
TTM Avg
14.88%
3Y Avg
13.50%
5Y Avg
6.84%
Market Cap
$500.30M
Operating Margin
10.00%
TTM Avg
8.23%
3Y Avg
4.46%
5Y Avg
2.51%
Market Cap
$488.00M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
Market Cap
$509.10M
Operating Margin
0.00%
TTM Avg
-620906.82%
3Y Avg
-450471.78%
5Y Avg
-300340.85%
Market Cap
$510.37M
Operating Margin
-46.01%
TTM Avg
-85.84%
3Y Avg
-83.08%
5Y Avg
-67.71%
Market Cap
$478.21M
Operating Margin
-36.19%
TTM Avg
-55.58%
3Y Avg
-82.00%
5Y Avg
-57.61%
Market Cap
$477.61M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$475.84M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $495.09M | 0.00% | -3261.87% | 0.00% | 0.00% |
| Puma Biotechnology, Inc. (PBYI)vs › | $489.40M | 13.16% | 14.88% | 13.50% | 6.84% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.30M | 10.00% | 8.23% | 4.46% | 2.51% |
| Evolus, Inc. (EOLS)vs › | $488.00M | -7.33% | -12.79% | -23.47% | -68.20% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | 0.00% | -620906.82% | -450471.78% | -300340.85% |
| 908 Devices Inc. (MASS)vs › | $510.37M | -46.01% | -85.84% | -83.08% | -67.71% |
| Alpha Teknova, Inc. (TKNO)vs › | $478.21M | -36.19% | -55.58% | -82.00% | -57.61% |
| Cerus Corporation (CERS)vs › | $477.61M | -0.73% | -6.05% | -13.09% | -25.54% |
| Arvinas, Inc. (ARVN)vs › | $475.84M | -43.75% | -69.37% | -212.63% | -278.07% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $475.44M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | -8352.26% |
| 2025-06-30 | -7957.09% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -2901.21% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
